Discontinued — last reported Q4 '24
country_US excluding Other Net Sales — Net Sales
Boston Scientific country_US excluding Other Net Sales — Net Sales remained flat by 0.0% to $2.55B in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 21.2%, from $2.11B to $2.55B. Over 3 years (FY 2021 to FY 2024), country_US excluding Other Net Sales — Net Sales shows an upward trend with a 13.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing market share or higher demand for the company's medical devices in the U.S., while a decrease may signal competitive pressure, pricing challenges, or reduced procedure volumes.
Detailed definition
This metric represents the total revenue generated from the sale of medical devices and related services within the Unit...
Peer comparison
Peers in the medical device industry typically report geographic revenue splits, allowing for comparison of U.S. market growth rates and regional commercial execution.
bsx_segment_country_us_excluding_other_net_sales_net_salesHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | $6.90B | $7.63B | $8.43B | $10.21B |
| YoY Change | — | +10.6% | +10.4% | +21.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's country_us excluding other net sales — net sales?
- Boston Scientific (BSX) reported country_us excluding other net sales — net sales of $2.55B in Q4 2024.
- How has Boston Scientific's country_us excluding other net sales — net sales changed year-over-year?
- Boston Scientific's country_us excluding other net sales — net sales increased by 21.2% year-over-year, from $2.11B to $2.55B.
- What is the long-term trend for Boston Scientific's country_us excluding other net sales — net sales?
- Over 3 years (2021 to 2024), Boston Scientific's country_us excluding other net sales — net sales has grown at a 13.9% compound annual growth rate (CAGR), from $6.90B to $10.21B.
- What does country_us excluding other net sales — net sales mean?
- The total revenue earned from core medical device sales within the United States.